Industry Research Reports

Home > Reports > Service & Software > Radioembolization Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Radioembolization Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-14

Pages: 102 Pages

Report ld: 6914273

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Radioembolization Therapy was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Radioembolization Therapy, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Radioembolization Therapy market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Radioembolization Therapy.

MARKET SEGMENTATION

By Company

Terumo Corporation
Merit Medical Systems Inc.
Cook Medical
Boston Scientific Corporation
Medtronic plc
Stryker Corporation
Depuy Synthes (J&J)
BTG International Limited

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Transarterial Radioembolization (TARE)
Selective Internal Radiation Therapy (SIRT)

Segment by Application

Hospital
Clinics
Ambulatory Surgical Centers
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Radioembolization Therapy companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Radioembolization Therapy revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Radioembolization Therapy revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Radioembolization Therapy Product Introduction

1.2 Global Radioembolization Therapy Market Size Forecast (2021–2032)

1.3 Radioembolization Therapy Market Trends & Drivers

1.3.1 Radioembolization Therapy Industry Trends

1.3.2 Radioembolization Therapy Market Drivers & Opportunities

1.3.3 Radioembolization Therapy Market Challenges

1.3.4 Radioembolization Therapy Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Radioembolization Therapy Players Revenue Ranking (2025)

2.2 Global Radioembolization Therapy Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Radioembolization Therapy Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Radioembolization Therapy

2.6 Radioembolization Therapy Market Competitive Analysis

2.6.1 Radioembolization Therapy Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Radioembolization Therapy Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Radioembolization Therapy revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Radioembolization Therapy Market Classification

3.1 Introduction by Type

3.1.1 Transarterial Radioembolization (TARE)

3.1.2 Selective Internal Radiation Therapy (SIRT)

3.1.3 Global Radioembolization Therapy Sales Value by Type

3.1.3.1 Global Radioembolization Therapy Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Radioembolization Therapy Sales Value, by Type (2021–2032)

3.1.3.3 Global Radioembolization Therapy Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinics

4.1.3 Ambulatory Surgical Centers

4.1.4 Other

4.2 Global Radioembolization Therapy Sales Value by Application

4.2.1 Global Radioembolization Therapy Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Radioembolization Therapy Sales Value by Application (2021–2032)

4.2.3 Global Radioembolization Therapy Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Radioembolization Therapy Sales Value by Region

5.1.1 Global Radioembolization Therapy Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Radioembolization Therapy Sales Value by Region (2021–2026)

5.1.3 Global Radioembolization Therapy Sales Value by Region (2027–2032)

5.1.4 Global Radioembolization Therapy Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Radioembolization Therapy Sales Value, 2021–2032

5.2.2 North America Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Radioembolization Therapy Sales Value, 2021–2032

5.3.2 Europe Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Radioembolization Therapy Sales Value, 2021–2032

5.4.2 Asia Pacific Radioembolization Therapy Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Radioembolization Therapy Sales Value, 2021–2032

5.5.2 South America Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Radioembolization Therapy Sales Value, 2021–2032

5.6.2 Middle East & Africa Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Radioembolization Therapy Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Radioembolization Therapy Sales Value, 2021–2032

6.3 United States

6.3.1 United States Radioembolization Therapy Sales Value, 2021–2032

6.3.2 United States Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Radioembolization Therapy Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Radioembolization Therapy Sales Value, 2021–2032

6.4.2 Europe Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Radioembolization Therapy Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Radioembolization Therapy Sales Value, 2021–2032

6.5.2 China Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

6.5.3 China Radioembolization Therapy Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Radioembolization Therapy Sales Value, 2021–2032

6.6.2 Japan Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Radioembolization Therapy Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Radioembolization Therapy Sales Value, 2021–2032

6.7.2 South Korea Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Radioembolization Therapy Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Radioembolization Therapy Sales Value, 2021–2032

6.8.2 Southeast Asia Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Radioembolization Therapy Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Radioembolization Therapy Sales Value, 2021–2032

6.9.2 India Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

6.9.3 India Radioembolization Therapy Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Terumo Corporation

7.1.1 Terumo Corporation Profile

7.1.2 Terumo Corporation Main Business

7.1.3 Terumo Corporation Radioembolization Therapy Products, Services, and Solutions

7.1.4 Terumo Corporation Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.1.5 Terumo Corporation Recent Developments

7.2 Merit Medical Systems Inc.

7.2.1 Merit Medical Systems Inc. Profile

7.2.2 Merit Medical Systems Inc. Main Business

7.2.3 Merit Medical Systems Inc. Radioembolization Therapy Products, Services, and Solutions

7.2.4 Merit Medical Systems Inc. Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.2.5 Merit Medical Systems Inc. Recent Developments

7.3 Cook Medical

7.3.1 Cook Medical Profile

7.3.2 Cook Medical Main Business

7.3.3 Cook Medical Radioembolization Therapy Products, Services, and Solutions

7.3.4 Cook Medical Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.3.5 Cook Medical Recent Developments

7.4 Boston Scientific Corporation

7.4.1 Boston Scientific Corporation Profile

7.4.2 Boston Scientific Corporation Main Business

7.4.3 Boston Scientific Corporation Radioembolization Therapy Products, Services, and Solutions

7.4.4 Boston Scientific Corporation Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.4.5 Boston Scientific Corporation Recent Developments

7.5 Medtronic plc

7.5.1 Medtronic plc Profile

7.5.2 Medtronic plc Main Business

7.5.3 Medtronic plc Radioembolization Therapy Products, Services, and Solutions

7.5.4 Medtronic plc Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.5.5 Medtronic plc Recent Developments

7.6 Stryker Corporation

7.6.1 Stryker Corporation Profile

7.6.2 Stryker Corporation Main Business

7.6.3 Stryker Corporation Radioembolization Therapy Products, Services, and Solutions

7.6.4 Stryker Corporation Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.6.5 Stryker Corporation Recent Developments

7.7 Depuy Synthes (J&J)

7.7.1 Depuy Synthes (J&J) Profile

7.7.2 Depuy Synthes (J&J) Main Business

7.7.3 Depuy Synthes (J&J) Radioembolization Therapy Products, Services, and Solutions

7.7.4 Depuy Synthes (J&J) Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.7.5 Depuy Synthes (J&J) Recent Developments

7.8 BTG International Limited

7.8.1 BTG International Limited Profile

7.8.2 BTG International Limited Main Business

7.8.3 BTG International Limited Radioembolization Therapy Products, Services, and Solutions

7.8.4 BTG International Limited Radioembolization Therapy Revenue (US$ Million), 2021–2026

7.8.5 BTG International Limited Recent Developments

8 Industry Chain Analysis

8.1 Radioembolization Therapy Value Chain

8.2 Radioembolization Therapy Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Radioembolization Therapy Sales Model

8.5.2 Sales Channels

8.5.3 Radioembolization Therapy Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Radioembolization Therapy Market Trends

Table 2. Radioembolization Therapy Market Drivers & Opportunities

Table 3. Radioembolization Therapy Market Challenges

Table 4. Radioembolization Therapy Market Restraints

Table 5. Global Radioembolization Therapy Revenue by Company (US$ Million), 2021–2026

Table 6. Global Radioembolization Therapy Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Radioembolization Therapy Product Type

Table 9. Key Companies General Availability (GA) Timeline for Radioembolization Therapy

Table 10. Global Radioembolization Therapy Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Radioembolization Therapy revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Radioembolization Therapy Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Radioembolization Therapy Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Radioembolization Therapy Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Radioembolization Therapy Sales Market Share in Value by Type (2021–2026)

Table 17. Global Radioembolization Therapy Sales Market Share in Value by Type (2027–2032)

Table 18. Global Radioembolization Therapy Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Radioembolization Therapy Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Radioembolization Therapy Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Radioembolization Therapy Sales Market Share in Value by Application (2021–2026)

Table 22. Global Radioembolization Therapy Sales Market Share in Value by Application (2027–2032)

Table 23. Global Radioembolization Therapy Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Radioembolization Therapy Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Radioembolization Therapy Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Radioembolization Therapy Sales Value by Region (%), 2021–2026

Table 27. Global Radioembolization Therapy Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Radioembolization Therapy Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Radioembolization Therapy Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Radioembolization Therapy Sales Value, (US$ Million), 2027–2032

Table 31. Terumo Corporation Basic Information List

Table 32. Terumo Corporation Description and Business Overview

Table 33. Terumo Corporation Radioembolization Therapy Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Radioembolization Therapy Business of Terumo Corporation (2021–2026)

Table 35. Terumo Corporation Recent Developments

Table 36. Merit Medical Systems Inc. Basic Information List

Table 37. Merit Medical Systems Inc. Description and Business Overview

Table 38. Merit Medical Systems Inc. Radioembolization Therapy Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Radioembolization Therapy Business of Merit Medical Systems Inc. (2021–2026)

Table 40. Merit Medical Systems Inc. Recent Developments

Table 41. Cook Medical Basic Information List

Table 42. Cook Medical Description and Business Overview

Table 43. Cook Medical Radioembolization Therapy Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Radioembolization Therapy Business of Cook Medical (2021–2026)

Table 45. Cook Medical Recent Developments

Table 46. Boston Scientific Corporation Basic Information List

Table 47. Boston Scientific Corporation Description and Business Overview

Table 48. Boston Scientific Corporation Radioembolization Therapy Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Radioembolization Therapy Business of Boston Scientific Corporation (2021–2026)

Table 50. Boston Scientific Corporation Recent Developments

Table 51. Medtronic plc Basic Information List

Table 52. Medtronic plc Description and Business Overview

Table 53. Medtronic plc Radioembolization Therapy Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Radioembolization Therapy Business of Medtronic plc (2021–2026)

Table 55. Medtronic plc Recent Developments

Table 56. Stryker Corporation Basic Information List

Table 57. Stryker Corporation Description and Business Overview

Table 58. Stryker Corporation Radioembolization Therapy Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Radioembolization Therapy Business of Stryker Corporation (2021–2026)

Table 60. Stryker Corporation Recent Developments

Table 61. Depuy Synthes (J&J) Basic Information List

Table 62. Depuy Synthes (J&J) Description and Business Overview

Table 63. Depuy Synthes (J&J) Radioembolization Therapy Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Radioembolization Therapy Business of Depuy Synthes (J&J) (2021–2026)

Table 65. Depuy Synthes (J&J) Recent Developments

Table 66. BTG International Limited Basic Information List

Table 67. BTG International Limited Description and Business Overview

Table 68. BTG International Limited Radioembolization Therapy Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Radioembolization Therapy Business of BTG International Limited (2021–2026)

Table 70. BTG International Limited Recent Developments

Table 71. Revenue (US$ Million) in Radioembolization Therapy Business of Company 40 (2021–2026)

Table 72. Company 40 Recent Developments

Table 73. Key Raw Materials Lists

Table 74. Key Suppliers of Raw Materials Lists

Table 75. Radioembolization Therapy Downstream Customers

Table 76. Radioembolization Therapy Distributors List

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

List of Figures

Figure 1. Radioembolization Therapy Product Picture

Figure 2. Global Radioembolization Therapy Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 4. Radioembolization Therapy Report Years Considered

Figure 5. Global Radioembolization Therapy Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Radioembolization Therapy Revenue in 2025

Figure 7. Radioembolization Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Transarterial Radioembolization (TARE) Picture

Figure 9. Selective Internal Radiation Therapy (SIRT) Picture

Figure 10. Global Radioembolization Therapy Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Radioembolization Therapy Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Hospital

Figure 13. Product Picture of Clinics

Figure 14. Product Picture of Ambulatory Surgical Centers

Figure 15. Product Picture of Other

Figure 16. Global Radioembolization Therapy Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Radioembolization Therapy Sales Value Market Share by Application, 2025 & 2032

Figure 18. North America Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 19. North America Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

Figure 20. Europe Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 21. Europe Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

Figure 22. Asia Pacific Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 23. Asia Pacific Radioembolization Therapy Sales Value by Subregion (%), 2025 vs 2032

Figure 24. South America Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 25. South America Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

Figure 26. Middle East & Africa Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 27. Middle East & Africa Radioembolization Therapy Sales Value by Country (%), 2025 vs 2032

Figure 28. Key Countries/Regions Radioembolization Therapy Sales Value (%), 2021–2032

Figure 29. United States Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 30. United States Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

Figure 31. United States Radioembolization Therapy Sales Value by Application (%), 2025 vs 2032

Figure 32. Europe Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 33. Europe Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

Figure 34. Europe Radioembolization Therapy Sales Value by Application (%), 2025 vs 2032

Figure 35. China Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 36. China Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

Figure 37. China Radioembolization Therapy Sales Value by Application (%), 2025 vs 2032

Figure 38. Japan Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 39. Japan Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

Figure 40. Japan Radioembolization Therapy Sales Value by Application (%), 2025 vs 2032

Figure 41. South Korea Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 42. South Korea Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

Figure 43. South Korea Radioembolization Therapy Sales Value by Application (%), 2025 vs 2032

Figure 44. Southeast Asia Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 45. Southeast Asia Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

Figure 46. Southeast Asia Radioembolization Therapy Sales Value by Application (%), 2025 vs 2032

Figure 47. India Radioembolization Therapy Sales Value (US$ Million), 2021–2032

Figure 48. India Radioembolization Therapy Sales Value by Type (%), 2025 vs 2032

Figure 49. India Radioembolization Therapy Sales Value by Application (%), 2025 vs 2032

Figure 50. Radioembolization Therapy Value Chain

Figure 51. Radioembolization Therapy Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Radioembolization Therapy market? zhanKai

The top companies in the global Radioembolization Therapy market are Terumo Corporation、Merit Medical Systems Inc.、Cook Medical.

Related Reports

Global Radioembolization Therapy Market Research Report 2026
The global Radioembolization Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 110
USD 2900.00
(Single User License)
Global Radioembolization Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Radioembolization Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 123
USD 4900.00
(Single User License)
Global Radioembolization Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Radioembolization Therapy market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 78
USD 4250.00
(Single User License)
Radioembolization Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Radioembolization Therapy was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 85
USD 3950.00
(Single User License)
Global Radioembolization Therapy Market Research Report 2025
The global market for Radioembolization Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 71
USD 2900.00
(Single User License)
Global Radioembolization Therapy Market Insights, Forecast to 2030
Market Analysis and Insights: Global Radioembolization Therapy Market
Published Date: 2024-04-18
Pages: 90
USD 4900.00
(Single User License)
Global Radioembolization Therapy Market Research Report 2024
The global Radioembolization Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 78
USD 2900.00
(Single User License)
Radioembolization Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Radioembolization Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 81
USD 3950.00
(Single User License)

Global Radioembolization Therapy Market Research Report 2026
The global Radioembolization Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 110
USD 2900.00 (Single User License)
Global Radioembolization Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Radioembolization Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 123
USD 4900.00 (Single User License)
Global Radioembolization Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Radioembolization Therapy market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 78
USD 4250.00 (Single User License)
Radioembolization Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Radioembolization Therapy was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 85
USD 3950.00 (Single User License)
Global Radioembolization Therapy Market Research Report 2025
The global market for Radioembolization Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 71
USD 2900.00 (Single User License)
Global Radioembolization Therapy Market Insights, Forecast to 2030
Market Analysis and Insights: Global Radioembolization Therapy Market
Published: 2024-04-18
Pages: 90
USD 4900.00 (Single User License)
Global Radioembolization Therapy Market Research Report 2024
The global Radioembolization Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 78
USD 2900.00 (Single User License)
Radioembolization Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Radioembolization Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 81
USD 3950.00 (Single User License)